Fda Label For Botox 2024. The fda has approved a new botulinum toxin formulation for aesthetic use in the us. The following document was submitted to the fda by the labeler of this product guangzhou yanxi biotechnology co., ltd.
Today, allergan aesthetics, an abbvie company announced the u.s. Fda approval history for botox (onabotulinumtoxina) used to treat hyperhidrosis, cervical dystonia, urinary incontinence, migraine prevention, upper limb spasticity, lower.